OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Enhancing these processes involves adjusting various parameters, including cell line development, media ingredients, and bioreactor environments. A key goal is to maximize antibody titer while lowering production co